Caricamento...
Pharmacogenomic findings from clinical whole exome sequencing of diagnostic odyssey patients
BACKGROUND: We characterized the pharmacogenomics (PGx) results received by diagnostic odyssey patients as secondary findings during clinical whole exome sequencing (WES) testing as a part of their care in Mayo Clinic's Individualized Medicine Clinic to determine the potential benefits and limi...
Salvato in:
| Pubblicato in: | Mol Genet Genomic Med |
|---|---|
| Autori principali: | , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley and Sons Inc.
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5441410/ https://ncbi.nlm.nih.gov/pubmed/28546997 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mgg3.283 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|